Literature DB >> 5485268

Effect of insulin and of alloxan diabetes on growth of the rat mammary carcinoma in vivo.

J C Heuson, N Legros.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5485268     DOI： 10.1016/0014-2964(70)90100-3

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  7 in total

1.  Antineoplastic efficacy of melphalan and N-(2-chloroethyl)-N-nitrosocarbamoyl-omega-lysine, in combination with diazoxide or insulin in autochthonous mammary carcinoma of the Sprague-Dawley rat.

Authors:  T Klenner; M R Berger; O Zelezny; M Fink; D Schmähl
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Discovery of an Orally Efficacious Imidazo[5,1-f][1,2,4]triazine Dual Inhibitor of IGF-1R and IR.

Authors:  Meizhong Jin; Prafulla C Gokhale; Andy Cooke; Kenneth Foreman; Elizabeth Buck; Earl W May; Lixin Feng; Mark A Bittner; Mridula Kadalbajoo; Darla Landfair; Kam W Siu; Kathryn M Stolz; Douglas S Werner; Radoslaw S Laufer; An-Hu Li; Hanqing Dong; Arno G Steinig; Andrew Kleinberg; Yan Yao; Jonathan A Pachter; Robert Wild; Mark J Mulvihill
Journal:  ACS Med Chem Lett       Date:  2010-08-30       Impact factor: 4.345

3.  Insulin-tumour interrelationship in EL4 lymphoma or thymoma-bearing mice. I. Alloxan-diabetic or non-diabetic mice.

Authors:  D Yam; A Zilberstein; A Fink; I Nir
Journal:  Br J Cancer       Date:  1990-05       Impact factor: 7.640

Review 4.  Mammary gland neoplasia in long-term rodent studies.

Authors:  I H Russo; J Russo
Journal:  Environ Health Perspect       Date:  1996-09       Impact factor: 9.031

Review 5.  Modulation of insulin-like growth factor-1 receptor and its signaling network for the treatment of cancer: current status and future perspectives.

Authors:  Meizhong Jin; Elizabeth Buck; Mark J Mulvihill
Journal:  Oncol Rev       Date:  2013-04-22

Review 6.  Dietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancer.

Authors:  R J Klement; M K Fink
Journal:  Oncogenesis       Date:  2016-02-15       Impact factor: 7.485

Review 7.  Insulin resistance and hyperinsulinaemia in the development and progression of cancer.

Authors:  Ian F Godsland
Journal:  Clin Sci (Lond)       Date:  2009-11-23       Impact factor: 6.124
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.